ChemistrySelect
From Resistance to Renewal: Design Strategies and Structure–Activity Relationships of Novel EGFR Inhibitors in Breast Cancer: Mini Review
ABSTRACT Breast cancer continues to be one of the top causes of cancer death globally, with triple‐negative breast cancer (TNBC) being the most aggressive variety as it has a much poorer prognosis, strong propensity for metastases, and fewer effective targeted therapies available. The increased expression of the epidermal growth factor receptor (EGFR) is essential for cancer cell growth, survival, migration, and drug resistance making EGFR a good target for therapy. However, the effectiveness of EGFR inhibitors has …